FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution

ALISO VIEJO, Calif., July 30, 2015 /PRNewswire/ — Sentrian, the Remote Patient Intelligence™ company aspiring to eliminate all preventable hospitalization, recently received confirmation from the Food & Drug Administration (FDA) that its Remote Patient Intelligence (RPI) solution meets the definition of a “medical device” for which the FDA intends to exercise “Enforcement Discretion.” The designation identifies medical devices…